Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly gets its Lantus copycat Basaglar approved by FDA—but not as a biosimilar
Lilly gets its Lantus copycat Basaglar approved by FDA—but not as a biosimilar
Lilly gets its Lantus copycat Basaglar approved by FDA—but not as a biosimilar
Submitted by
admin
on December 17, 2015 - 2:00pm
Source:
BioPharma Dive
News Tags:
diabetes
Eli Lilly
Lantus
Basaglar
insulin
FDA
biosimilars
Sanofi
Headline:
Lilly gets its Lantus copycat Basaglar approved by FDA—but not as a biosimilar
Do Not Allow Advertisers to Use My Personal information
